Escoubet B, Silve C
Département de Physiologie, Faculté de Médecine X. Bichat, Université Paris 7, INSERM U251, France.
Nephrologie. 1992;13(3):115-21.
Familial hypophosphatemia are either primitive disorders of renal phosphate handling, isolated as in X linked hypophosphatemic rickets (XLHR) or associated with alterations of renal handling of other solutes. They can also occur in the course of a number of other inherited diseases such as vitamin D dependent rickets type I or II and distal tubular acidosis. The molecular basis of most of these diseases are unknown. Chronic hypophosphatemia induces an alteration of bone mineralisation with rickets in children and osteomalacia in children and adults. Hypophosphatemia and the bone disease are most important in XLHR or VDDR. Treatment with oral phosphate and 1 alpha hydroxylated vitamin D metabolites, and in some cases calcium, tends to correct the hypophosphatemia and the bone disease. Treatment of the associated metabolic disorder in certain Fanconi syndromes can correct hypophosphatemia. In the forms associated with hypocalcemia, phosphate therapy is not indicated, but rather calcium therapy.
家族性低磷血症要么是肾脏磷酸盐处理的原发性疾病,如孤立的X连锁低磷性佝偻病(XLHR),要么与其他溶质的肾脏处理改变有关。它们也可发生在许多其他遗传性疾病过程中,如I型或II型维生素D依赖性佝偻病以及远端肾小管酸中毒。这些疾病大多数的分子基础尚不清楚。慢性低磷血症会导致儿童佝偻病和儿童及成人骨软化症,引起骨矿化改变。低磷血症和骨病在XLHR或VDDR中最为重要。口服磷酸盐和1α-羟基化维生素D代谢物,以及在某些情况下使用钙进行治疗,往往可以纠正低磷血症和骨病。某些范可尼综合征相关代谢紊乱的治疗可以纠正低磷血症。在与低钙血症相关的类型中,不建议进行磷酸盐治疗,而应进行钙治疗。